Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Independent panel recommends that pivotal Flocor trial for sickle cell crisis proceed

Jan. 14, 1999

Sydnonimine derivatives for cardiovascular disorders presented by Chugai

Jan. 13, 1999

Intravenous adenosine for MI advances to phase III

Jan. 12, 1999

China Pharmaceutical University presents new antiarrhythmic series

Jan. 12, 1999

Series of Na+/H+ exchange inhibitors developed at Toa Eiyo

Jan. 12, 1999

Orally bioavailable agents for vascular wall hypertrophy described by Kissei

Jan. 12, 1999

New Canadian biotherapeutics company will develop SERP1 for antiinflammatory indications

Jan. 12, 1999

Chinese scientists design potent antihypertensive agents

Jan. 11, 1999

RPR Gencell evaluates SARP-1 gene for cardiovascular indications under agreement with LXR

Jan. 11, 1999

Pursuit of pediatric data for lisinopril will extend Zeneca's U.S. market exclusivity

Jan. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...